EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS

被引：0
|
作者：
Portolese, Olivia [1 ]
Bilodeau, Marc [2 ]
Castel, Helene [1 ]
Willems, Bernard E. [1 ]
Huard, Genevieve [1 ]
Vincent, Catherine [2 ]
Lavoie, Annick [1 ]
Hercun, Julian [1 ]
机构：
[1] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1708-A
引用
收藏
页码：S638 / S639
页数：2
相关论文
共 50 条
  • [21] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [22] Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
    Piehler, Linus
    Thalemann, Ralf
    Lehmann, Christine
    Thee, Stephanie
    Roehmel, Jobst
    Syunyaeva, Zulfiya
    Stahl, Mirjam
    Mall, Marcus A.
    Graeber, Simon Y.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [23] Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis
    Steinack, Carolin
    Ernst, Matthias
    Beuschlein, Felix
    Hage, Rene
    Roeder, Maurice
    Schuurmans, Mace M.
    Schmid, Christoph
    Gaisl, Thomas
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (04) : 722 - 729
  • [24] Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis
    Safirstein, Julie
    Grant, Jonathan J.
    Clausen, Emily
    Savant, Deepika
    Dezube, Rebecca
    Hong, Gina
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (03) : 506 - 510
  • [25] The effect of elexacaftor/tezacaftor/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis
    Allgood, Sarah
    Levy, Reena
    Bubaris, Despina
    Riekert, Kristin
    Psoter, Kevin J.
    Lechtzin, Noah
    HELIYON, 2023, 9 (09)
  • [26] Limited effectiveness of elexacaftor-tezacaftor-ivacaftor on lung hyperinflation in adults with cystic fibrosis
    Dhote, Theo
    Martin, Clemence
    Regard, Lucile
    Kanaan, Reem
    Carlier, Nicolas
    Honore, Isabelle
    Fesenbeckh, Johanna
    Burnet, Esperie
    Fajac, Isabelle
    Aubourg, Frederique
    Perez, Thierry
    Da Silva, Jennifer
    Burgel, Pierre-Regis
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [27] Elexacaftor/Tezacaftor/Ivacaftor use in Pediatric Cystic Fibrosis Patients with Advanced Liver Disease
    Protich, Hannah E.
    Molleston, Jean P.
    Bozic, Molly
    Pettit, Rebecca S.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (06) : 1122 - 1128
  • [28] Cardiometabolic risk factors in adults with cystic fibrosis undergoing elexacaftor/tezacaftor/ivacaftor therapy
    Gramegna, Andrea
    Ruscica, Massimiliano
    Leonardi, Gloria
    Macchi, Chiara
    Fichtner, Isabella
    Putti, Gianmarco
    Schianca, Margherita Carnevale
    Terranova, Leonardo
    Alicandro, Gianfranco
    Blasi, Francesco
    JOURNAL OF CYSTIC FIBROSIS, 2025, 24 (01) : 53 - 56
  • [29] Effects of elexacaftor-tezacaftor-ivacaftor on daily treatment burden and airflow obstruction in adults with cystic fibrosis
    Tiotiu, Angelica
    Ioan, Iulia
    Billon, Yves
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 82
  • [30] THE USE OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN PATIENTS WITH CYSTIC FIBROSIS POST-LIVER TRANSPLANTATION
    Ragan, H. H.
    Autry, E.
    Bomersback, T.
    Hewlett, J.
    Kormelink, L.
    Safirstein, J.
    Shanley, L.
    Lubsch, L.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S349 - S350
12345